Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO
Not Applicable
Completed
- Conditions
- Cardiogenic Shock
- Interventions
- Diagnostic Test: Blood testsDevice: oXiris membrane
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT05642273
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Utilizing of Augmented Reality Technology Education Program for Nurse
Not Applicable
Completed
- Conditions
- EducationNursing
- Interventions
- Device: AR guidance with Hololens 2
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05629663
- Locations
- π°π·
Samsung Medical Centre, Seoul, Korea, Republic of
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
Phase 2
Recruiting
- Conditions
- Hepatocellular CarcinomaPortal Vein Thrombosis
- Interventions
- Radiation: PBT and atezolizumab/bevacizumab
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT05625893
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Prospective Pecutaneous Coronary Intervention Registry
Recruiting
- Conditions
- Coronary Artery DiseasePercutaneous Coronary Intervention
- Interventions
- Procedure: Percutaneous coronary intervention
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 15000
- Registration Number
- NCT05624905
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
The Exploratory Study of AR-based Home Rehabilitation Exercise Combined With Wearable Sensor (IMU) in the Elderly
Not Applicable
Recruiting
- Conditions
- TelerehabilitationGeriatricsExercise
- Interventions
- Device: OASIS Pro
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2022-11-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT05598463
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
Recruiting
- Conditions
- Rectal CancerRectosigmoid CancerRectosigmoid Junction Cancer
- Interventions
- Device: ArtiSential
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT05566249
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT05528458
- Locations
- π°π·
Sehoon Lee, Seoul, Korea, Republic of
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Phase 4
Recruiting
- Conditions
- Multi Vessel Coronary Artery DiseaseCardiogenic ShockExtracorporeal Membrane OxygenationAcute Myocardial Infarction
- Interventions
- Procedure: Immediate multi-vessel PCIProcedure: Culprit lesion only PCI
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 560
- Registration Number
- NCT05527717
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
- Conditions
- Body CompositionRocuronium
- Interventions
- Device: body composition analysis
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT05515835
- Locations
- π°π·
Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Republic of
Body Composition Analysis and Time to Emergence From Remimazolam
- Conditions
- RemimazolamBody Composition
- Interventions
- Device: body composition analysis
- First Posted Date
- 2022-08-23
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT05512559
- Locations
- π°π·
Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath